Along with other biotech stocks, Atha Stock Price is up 14.04% from last month.
On average, analysts who follow Atha Stock expect it to climb 447.34% in the next twelve months. And for the next twelve months, the estimated Atha Stock price target is around $14 to $15.
According to the same analysts, the stock is rated as a Buy on average. That average rating earns Atha Stock and Analyst Ranking of 30, which means it ranks higher than 30 of all stocks.
Before diving further, let’s learn about Athira Pharma Inc.
A Brief Overview of Athira Pharma Inc
Athira Pharma Inc is a biotechnology company focusing on developing smaller molecules to restore neuronal health and prevent neurodegeneration. In addition, the company is working on treatments for Alzheimer’s and Parkinson’s disease. Athira Pharma, Inc. was previously known as M3 Biotechnology, Inc. and switched its name to Athira Pharma, Inc. in April 2019. The company was established in 2011, and its headquarters is in Bothell, Washington.
Market Sentiments For Atha Stock
Right now, Athira Pharma Inc is showing a Neutral market sentiment reading. And according to top analysts, Atha Stock has an overall rank of 46, which is below average.
Based on the fundamental outlook and an analysis of the stock’s chart, Athira Pharma Inc ranks in the bottom half of stocks.
What is Stock Sentiment?
Sentiment provides a good overview of stocks investors currently favor when making investment decisions. However, sentiment incorporates short-term technical analysis into its score.
Therefore, it does not encompass fundamental analysis, such as the company’s profitability.
What’s Going On With ATHA Stock Today?
Athira Pharma Inc (ATHA) stock is trading at 3.26 as of 11:54 PM on Monday, July 25th, a profit of +$0.05, or +1.55% from the previous closing price of $3.21 on Friday.
The stock has traded between $3.20 and $3.31 today. Stock Atha has a below-average volume today. So far, 133,550 new shares have traded compared to the average volume of 1,644,861.
Atha Sock News
Today there is not much Atha Sock News nor Atha StockTwits. Still, the company recently announced that Athira Pharma would present clinical and preclinical data at the #AAIC22 (Alzheimer’s Association International Conference 2022).
How to buy shares of Athira Pharma Inc?
Follow the steps below to buy the Atha Stocks:
- Sign up for an Exchange or Broker Account.
- Confirm your payment details. Fund your account.
- Search for the stock by name or ticker symbol (ATHA).
- Now you can place a spot order or even can trade on margin.
Is Athira Pharma, Inc. a good stock to buy?
Currently, market sentiments for Atha Stock are neutral, but if you are buying it for the long term, I suggest you to DCA (Dollar Cost Average). However, it will be wise to wait and DCA over time because we may enter a recession.
What are the predictions for Athira Pharma, Inc. (ATHA) stock?
Analysts predicted that with all the biotech boom, Atha stock is projected to increase 447.34% over the next year.
Final Thoughts
As in recent times, biotech stocks are up by double digits. Consequently, investors wonder whether it’s a bull trap or the bottom is already in.
As far as Atha stock forecast is concerned, analysts predicted that with all the biotech boom, Atha stock is expected to climb 447.34% over the next year.
Fingers Crossed for the future, and continuously invest what you afford to lose. Be legendary!
